O
Obsidio
0 followers
Obsidio is a medical device company pioneering a biomaterial platform technology to enable minimally-invasive occlusion of blood vessels.
Org chart
Michael F. Mahoney
Chairman & CEO
Collapse
Daniel J. Brennan
EVP & CFO
Jodi Eddy
SVP, Chief Information & Digital Officer
Mary Beth Moynihan
SVP, Market Access & Chief Marketing Officer
Vance R. Brown
SVP, General Counsel & Corporate Secretary
Joseph M. Fitzgerald
EVP & Group President, Cardiology
Arthur C. Butcher
EVP & Group President, MedSurg & Asia Pacific
Eric Thépaut
EVP & President, Europe, Middle East & Africa
Jeff Mirviss
EVP & President, Peripheral Interventions
Brad Sorenson
EVP, Global Operations
Wendy Carruthers
EVP, Human Resources
Stephen Morse
SVP & President, Asia Pacific
Scott Olson
SVP & President, Cardiac Rhythm Management & Diagnostics
Michael Jones
SVP & President, Endoscopy
Lance Bates
SVP & President, Interventional Cardiology Therapies
Meghan Scanlon
SVP & President, Urology and Pelvic Health
Rosaleen Burke
SVP, Global Quality & Regulatory
Charlie Attlan
SVP, New Business Development, Corporate Strategy & Portfolio
Kenneth Stein
Senior Vice President & Global Chief Medical Officer
Board & advisors
Nelda J. Connors
Board Member
Ellen M. Zane
Board Member
David S. Wichmann
Board Member
Edward J. Ludwig
Board Member
David Roux
Board Member
Charles J. Dockendorff
Board Member
Yoshiaki Fujimori
Board Member
John E. Sununu
Board Member
Jessica L. Mega
Board Member
Susan E. Morano
Board Member